Target intelligence / Profile preview

Coronin-2B (CORO2B)

Target
CORO2B
Molecular classification
Actin-binding protein, Cytoskeletal regulator, WD40-repeat domain protein
01

Overview

Coronin-2B (CORO2B) is a WD40-repeat-containing actin-binding protein that regulates the cytoskeleton in specialized cells such as neurons and podocytes[2][3]. It directly interacts with components of the actin cytoskeleton (e.g., cofilin, talin, vinculin), coordinates actin dynamics necessary for cell migration and adhesion, and modulates nucleolar function in neurons by supporting rDNA transcription through interaction with the upstream binding factor (UBF)[1][2][3][4]. Loss of CORO2B leads to structural and functional deficits, such as neuronal migration defects, nucleolar stress and apoptosis in neurons, increased susceptibility to seizures, and podocyte stress responses implicated in kidney injury[1][2][3]. Its specific expression in podocytes and neurons makes it a useful research marker for these cell types, but it is not yet a validated therapeutic target or clinical biomarker[2][3][4].

Other names
Coronin-2BCORO2BKIAA0925Clipin-CClipinCCoronin-like protein CProtein FC96clipin Ccoronin, actin-binding, 2BCLIPINCcoronin-2Bcoronin, actin binding protein, 2Bcoronin-like protein C
02

Mechanism of action

Not applicable; mechanisms described are protein–protein interactions (e.g., with UBF and cofilin) for cellular function, not for drug action

03

Biological functions

Regulation of actin cytoskeleton organizationModulation of focal adhesion turnoverRegulation of rDNA transcription and nucleolar functionNeuronal migration and morphogenesis
04

Disease associations

Cancer (through nucleolar stress and p53 pathway activation leading to apoptosis)Kidney disease (podocyte cytoskeleton dynamics and nephropathy susceptibility)Neurodevelopmental disorders (defects in neuronal migration leading to epilepsy and cortical malformations)
05

Safety considerations

Not documented; as there are no drugs targeting Coronin-2B, safety issues are not described in current research
06

Interacting drugs

None documented; there are currently no known drugs that interact directly with Coronin-2B in published literature
07

Biomarkers

Podocyte injury marker (proposed, due to podocyte-specific enrichment)Neuronal migration impairment (not established as a clinical biomarker)

Beyond the preview

Go deeper on Coronin-2B (CORO2B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coronin-2B (CORO2B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call